Literature DB >> 3115508

Metabolic oncologic emergencies.

D J Glover1, J H Glick.   

Abstract

With improvements in antitumor therapy, it is important to recognize life-threatening metabolic emergencies that may be reversed by prompt treatment. Accurate diagnosis and treatment of metabolic emergencies may both improve quality of life and increase survival, allowing more oncology patients to receive an adequate trial of definitive therapy designed to eradicate or palliate their disease.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3115508     DOI： 10.3322/canjclin.37.5.302

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


  5 in total

1.  Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM).

Authors:  E Sbardella; A M Isidori; G Arnaldi; M Arosio; C Barone; A Benso; R Berardi; G Capasso; M Caprio; F Ceccato; G Corona; S Della Casa; L De Nicola; M Faustini-Fustini; E Fiaccadori; L Gesualdo; S Gori; A Lania; G Mantovani; P Menè; G Parenti; C Pinto; R Pivonello; P Razzore; G Regolisti; C Scaroni; F Trepiccione; A Lenzi; A Peri
Journal:  J Endocrinol Invest       Date:  2017-11-20       Impact factor: 4.256

Review 2.  Thymoma calcification: is it clinically meaningful?

Authors:  Kassem Harris; Dany Elsayegh; Basem Azab; Homam Alkaied; Michel Chalhoub
Journal:  World J Surg Oncol       Date:  2011-08-23       Impact factor: 2.754

Review 3.  Common emergencies in cancer medicine: metabolic syndromes.

Authors:  C R Thomas; N Dodhia
Journal:  J Natl Med Assoc       Date:  1991-09       Impact factor: 1.798

Review 4.  Diagnosis and management of hyponatremia in cancer patients.

Authors:  Harry Raftopoulos
Journal:  Support Care Cancer       Date:  2007-08-14       Impact factor: 3.603

5.  Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study.

Authors:  Rossana Berardi; Candida Mastroianni; Giuseppe Lo Russo; Roberta Buosi; Daniele Santini; Agnese Montanino; Carlo Carnaghi; Marcello Tiseo; Rita Chiari; Andrea Camerini; Sandro Barni; Valeria De Marino; Daris Ferrari; Antonella Cristofano; Laura Doni; Federica Freddari; Daniele Fumagalli; Luigi Portalone; Roberta Sarmiento; Giovanni Schinzari; Francesca Sperandi; Marcello Tucci; Alessandro Inno; Libero Ciuffreda; Marita Mariotti; Cinzia Mariani; Miriam Caramanti; Mariangela Torniai; Rosaria Gallucci; Chiara Bennati; Paola Bordi; Lucio Buffoni; Achille Galeassi; Michele Ghidini; Emidio Grossi; Alessandro Morabito; Bruno Vincenzi; Emanuela Arvat
Journal:  Ther Adv Med Oncol       Date:  2019-09-27       Impact factor: 8.168
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.